Salvus Wealth Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.9K | Hold |
11,691
| – | – | 0.03% | 121 |
|
|
2025
Q1 | $75.8K | Hold |
11,691
| – | – | 0.05% | 116 |
|
|
2024
Q4 | $85.8K | Hold |
11,691
| – | – | 0.05% | 113 |
|
|
2024
Q3 | $87.6K | Hold |
11,691
| – | – | 0.05% | 112 |
|
|
2024
Q2 | $104K | Hold |
11,691
| – | – | 0.07% | 106 |
|
|
2024
Q1 | $118K | Hold |
11,691
| – | – | 0.08% | 102 |
|
|
2023
Q4 | $118K | Hold |
11,691
| – | – | 0.08% | 104 |
|
|
2023
Q3 | $110K | Buy |
+11,691
| New | +$110K | 0.09% | 100 |
|